Drawing for EM

USPTO serial 79142421

EM

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
MIDDLETON, BERNICE L
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products; therapeutic drugs and agents, namely antibody-based therapies, antibodies, antibody fragments, bispecific antibodies; T-cell bispecific antibodies; pharmaceutical preparations namely antibody engineering, antibody production and purification for the treatment of hematological malignancies, solids tumors and diseases of the immune system; namely multiple myeloma, chronic lymphocytic leukemia, acute myeloid leukemia, non-Hodgkin lymphomas, systemic lupus erythematosusSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 30, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
May 5, 2016FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 22, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 22, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 31, 2015OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 15, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 15, 2015OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 23, 2015MAB0ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE—
Mar 22, 2015ABN0ABANDONMENT - INCOMPLETE RESPONSE—
Feb 4, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 4, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 28, 2015ALIEASSIGNED TO LIE—
Jan 14, 2015ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 14, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 12, 2014CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 11, 2014CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 30, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 30, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 30, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 4, 2014RFNTREFUSAL PROCESSED BY IB—
Mar 19, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 19, 2014RFRRREFUSAL PROCESSED BY MPU—
Mar 19, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 18, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2014DOCKASSIGNED TO EXAMINER—
Feb 22, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 18, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 17, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance